Click here to get full coverage on SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Districts to Hold SPRC Training Sessions in Each District - Louisiana UMC

Districts to Hold SPRC Training Sessions in Each District  Louisiana UMC

Districts to Hold SPRC Training Sessions in Each District - Louisiana UMC

Click here to get full coverage on SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity - Stock Titan

SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity  Stock Titan

SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity - Stock Titan

Click here to get full coverage on DRILL SERGEANT TIMOTHY KAY SOLDIER PERFORMANCE READINESS CENTER (SPRC) - army.mil

DRILL SERGEANT TIMOTHY KAY SOLDIER PERFORMANCE READINESS CENTER (SPRC)  army.mil

DRILL SERGEANT TIMOTHY KAY SOLDIER PERFORMANCE READINESS CENTER (SPRC) - army.mil

Click here to get full coverage on Highs Report: Will SPRC stock benefit from sector rotation - Earnings Trend Report & Fast Entry High Yield Stock Tips - BỘ NỘI VỤ

Highs Report: Will SPRC stock benefit from sector rotation - Earnings Trend Report & Fast Entry High Yield Stock Tips  BỘ NỘI VỤ

Highs Report: Will SPRC stock benefit from sector rotation - Earnings Trend Report & Fast Entry High Yield Stock Tips - BỘ NỘI VỤ

Click here to get full coverage on SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com

SciSparc Shares Experience Pre-Bell Dip Following Quiet Session  timothysykes.com

SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com

Click here to get full coverage on The American Foundation for Suicide Prevention (AFSP) Earns Prestigious Recognition from Suicide Prevention Research Center (SPRC) for Talk Saves Lives Program - AFSP

The American Foundation for Suicide Prevention (AFSP) Earns Prestigious Recognition from Suicide Prevention Research Center (SPRC) for Talk Saves Lives Program  AFSP

The American Foundation for Suicide Prevention (AFSP) Earns Prestigious Recognition from Suicide Prevention Research Center (SPRC) for Talk Saves Lives Program - AFSP

Click here to get full coverage on Morning Market Movers: SPRC, APDN, EPSM, WOLF See Big Swings - RTTNews

Morning Market Movers: SPRC, APDN, EPSM, WOLF See Big Swings  RTTNews

Morning Market Movers: SPRC, APDN, EPSM, WOLF See Big Swings - RTTNews

Click here to get full coverage on SciSparc (Nasdaq: SPRC) NeuroThera signs term sheet for 55% quantum data stake - Stock Titan

SciSparc (Nasdaq: SPRC) NeuroThera signs term sheet for 55% quantum data stake  Stock Titan

SciSparc (Nasdaq: SPRC) NeuroThera signs term sheet for 55% quantum data stake - Stock Titan

Click here to get full coverage on SPRC Stock Soars: What’s Next? - StocksToTrade

SPRC Stock Soars: What’s Next?  StocksToTrade

SPRC Stock Soars: What’s Next? - StocksToTrade

Click here to get full coverage on Morning Market Movers: SPRC, HIND, SQFT, FGNX See Big Swings - RTTNews

Morning Market Movers: SPRC, HIND, SQFT, FGNX See Big Swings  RTTNews

Morning Market Movers: SPRC, HIND, SQFT, FGNX See Big Swings - RTTNews

Click here to get full coverage on SciSparc (Nasdaq: SPRC) signs MUSE GERD IP term sheet, plans 19.99% share issue - Stock Titan

SciSparc (Nasdaq: SPRC) signs MUSE GERD IP term sheet, plans 19.99% share issue  Stock Titan

SciSparc (Nasdaq: SPRC) signs MUSE GERD IP term sheet, plans 19.99% share issue - Stock Titan

Click here to get full coverage on SciSparc (Nasdaq: SPRC) Supports NeuroThera Israeli Patent for MEAI-PEA Depression Therapy - Stock Titan

SciSparc (Nasdaq: SPRC) Supports NeuroThera Israeli Patent for MEAI-PEA Depression Therapy  Stock Titan

SciSparc (Nasdaq: SPRC) Supports NeuroThera Israeli Patent for MEAI-PEA Depression Therapy - Stock Titan

Click here to get full coverage on US$11.6M Pharma Assets: SciSparc to Transfer Portfolio; Expected to Hold 75–84% of Miza - Stock Titan

US$11.6M Pharma Assets: SciSparc to Transfer Portfolio; Expected to Hold 75–84% of Miza  Stock Titan

US$11.6M Pharma Assets: SciSparc to Transfer Portfolio; Expected to Hold 75–84% of Miza - Stock Titan

Click here to get full coverage on U.S. patent application published for MEAI+PEA binge-disorder therapy — SciSparc & Clearmind, Oct 20 - Stock Titan

U.S. patent application published for MEAI+PEA binge-disorder therapy — SciSparc & Clearmind, Oct 20  Stock Titan

U.S. patent application published for MEAI+PEA binge-disorder therapy — SciSparc & Clearmind, Oct 20 - Stock Titan

Click here to get full coverage on $344B Cancer Drug Market: N2OFF Shareholders Greenlight MitoCareX Merger for Novel Cancer Therapies - Stock Titan

$344B Cancer Drug Market: N2OFF Shareholders Greenlight MitoCareX Merger for Novel Cancer Therapies  Stock Titan

$344B Cancer Drug Market: N2OFF Shareholders Greenlight MitoCareX Merger for Novel Cancer Therapies - Stock Titan

Click here to get full coverage on Israeli EV Importer AutoMax to Join Nasdaq Through SciSparc Reverse Merger, Expanding JAC EV Distribution - Stock Titan

Israeli EV Importer AutoMax to Join Nasdaq Through SciSparc Reverse Merger, Expanding JAC EV Distribution  Stock Titan

Israeli EV Importer AutoMax to Join Nasdaq Through SciSparc Reverse Merger, Expanding JAC EV Distribution - Stock Titan

Click here to get full coverage on $4.25M Repayment Plan: SciSparc & AutoMax Mutually Terminate Merger; $2M in Monthly Repayments - Stock Titan

$4.25M Repayment Plan: SciSparc & AutoMax Mutually Terminate Merger; $2M in Monthly Repayments  Stock Titan

$4.25M Repayment Plan: SciSparc & AutoMax Mutually Terminate Merger; $2M in Monthly Repayments - Stock Titan

Click here to get full coverage on SciSparc's Major 1:21 Reverse Split Cuts Shares from 11.2M to 534K: What Investors Must Know - Stock Titan

SciSparc's Major 1:21 Reverse Split Cuts Shares from 11.2M to 534K: What Investors Must Know  Stock Titan

SciSparc's Major 1:21 Reverse Split Cuts Shares from 11.2M to 534K: What Investors Must Know - Stock Titan

Click here to get full coverage on Clinical-Stage Pharma SciSparc Makes Bold Move into EV Market with AutoMax Merger Approval - Stock Titan

Clinical-Stage Pharma SciSparc Makes Bold Move into EV Market with AutoMax Merger Approval  Stock Titan

Clinical-Stage Pharma SciSparc Makes Bold Move into EV Market with AutoMax Merger Approval - Stock Titan

Click here to get full coverage on Revolutionary Quantum Computing Meets Drug Discovery: SciSparc's New AI Platform Targets Protein Modeling - Stock Titan

Revolutionary Quantum Computing Meets Drug Discovery: SciSparc's New AI Platform Targets Protein Modeling  Stock Titan

Revolutionary Quantum Computing Meets Drug Discovery: SciSparc's New AI Platform Targets Protein Modeling - Stock Titan

Click here to get full coverage on Why Is SciSparc Stock (SPRC) Up 130% Today? - TipRanks

Why Is SciSparc Stock (SPRC) Up 130% Today?  TipRanks

Why Is SciSparc Stock (SPRC) Up 130% Today? - TipRanks

Click here to get full coverage on SciSparc (Nasdaq: SPRC) closes MitoCareX sale; sellers to hold 40% of N2OFF (Nasdaq: NITO) - Stock Titan

SciSparc (Nasdaq: SPRC) closes MitoCareX sale; sellers to hold 40% of N2OFF (Nasdaq: NITO)  Stock Titan

SciSparc (Nasdaq: SPRC) closes MitoCareX sale; sellers to hold 40% of N2OFF (Nasdaq: NITO) - Stock Titan

Click here to get full coverage on SPRC Records Strong Financial Performance in 3Q25 with Significant Profit Growth - kaohoon international

SPRC Records Strong Financial Performance in 3Q25 with Significant Profit Growth  kaohoon international

SPRC Records Strong Financial Performance in 3Q25 with Significant Profit Growth - kaohoon international

Click here to get full coverage on SciSparc (NASDAQ: SPRC) closes Neurothera deal, 75% control via 63.3M shares - Stock Titan

SciSparc (NASDAQ: SPRC) closes Neurothera deal, 75% control via 63.3M shares  Stock Titan

SciSparc (NASDAQ: SPRC) closes Neurothera deal, 75% control via 63.3M shares - Stock Titan

Click here to get full coverage on SciSparc (NASDAQ: SPRC) to form subsidiary for quantum 3D protein modeling tools - Stock Titan

SciSparc (NASDAQ: SPRC) to form subsidiary for quantum 3D protein modeling tools  Stock Titan

SciSparc (NASDAQ: SPRC) to form subsidiary for quantum 3D protein modeling tools - Stock Titan

Click here to get full coverage on Why SciSparc Stock Is Gaining Today - Sahm

Why SciSparc Stock Is Gaining Today  Sahm

Why SciSparc Stock Is Gaining Today - Sahm

Click here to get full coverage on SPRC-TOP Slide amid Reports on Ukraine-Russia Peace Deal, Pressuring Oil Prices - kaohoon international

SPRC-TOP Slide amid Reports on Ukraine-Russia Peace Deal, Pressuring Oil Prices  kaohoon international

SPRC-TOP Slide amid Reports on Ukraine-Russia Peace Deal, Pressuring Oil Prices - kaohoon international

Click here to get full coverage on SciSparc jumps after deal to buy Xylo's medical device patents - TradingView

SciSparc jumps after deal to buy Xylo's medical device patents  TradingView

SciSparc jumps after deal to buy Xylo's medical device patents - TradingView

Click here to get full coverage on SciSparc Clears Critical Nasdaq Hurdle: Stock Maintains $1 Minimum for 10 Straight Days - Stock Titan

SciSparc Clears Critical Nasdaq Hurdle: Stock Maintains $1 Minimum for 10 Straight Days  Stock Titan

SciSparc Clears Critical Nasdaq Hurdle: Stock Maintains $1 Minimum for 10 Straight Days - Stock Titan

Click here to get full coverage on SciSparc Stock Soared 61% Today – Here’s An Important Update - Stocktwits

SciSparc Stock Soared 61% Today – Here’s An Important Update  Stocktwits

SciSparc Stock Soared 61% Today – Here’s An Important Update - Stocktwits

Click here to get full coverage on SPRC Names Herbert Matthew Payne II as New CEO and Director - kaohoon international

SPRC Names Herbert Matthew Payne II as New CEO and Director  kaohoon international

SPRC Names Herbert Matthew Payne II as New CEO and Director - kaohoon international

Click here to get full coverage on SciSparc Stock Soars: Time to Buy? - StocksToTrade

SciSparc Stock Soars: Time to Buy?  StocksToTrade

SciSparc Stock Soars: Time to Buy? - StocksToTrade

Click here to get full coverage on SciSparc stock rallies after AutoMax files motion on pending merger - MSN

SciSparc stock rallies after AutoMax files motion on pending merger  MSN

SciSparc stock rallies after AutoMax files motion on pending merger - MSN

Click here to get full coverage on SciSparc Stocks Surge: A Strategic Leap Forward? - timothysykes.com

SciSparc Stocks Surge: A Strategic Leap Forward?  timothysykes.com

SciSparc Stocks Surge: A Strategic Leap Forward? - timothysykes.com

Click here to get full coverage on SciSparc Ltd. Announces $2.2 Million Securities Offering - The Globe and Mail

SciSparc Ltd. Announces $2.2 Million Securities Offering  The Globe and Mail

SciSparc Ltd. Announces $2.2 Million Securities Offering - The Globe and Mail

Click here to get full coverage on Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside… - Barchart.com

Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside…  Barchart.com

Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside… - Barchart.com

Click here to get full coverage on SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems - GlobeNewswire

SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems  GlobeNewswire

SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems - GlobeNewswire

Click here to get full coverage on SciSparc Stock Soars But Is It Sustainable? - timothysykes.com

SciSparc Stock Soars But Is It Sustainable?  timothysykes.com

SciSparc Stock Soars But Is It Sustainable? - timothysykes.com

Click here to get full coverage on SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% - MSN

SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29%  MSN

SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% - MSN

Click here to get full coverage on SciSparc’s Stock Slip: Investment Opportunity? - timothysykes.com

SciSparc’s Stock Slip: Investment Opportunity?  timothysykes.com

SciSparc’s Stock Slip: Investment Opportunity? - timothysykes.com

Click here to get full coverage on SciSparc Ltd. (SPRC) Stock: Soars 50% on Bold Move into Quantum-Powered Drug Discovery - parameter.io

SciSparc Ltd. (SPRC) Stock: Soars 50% on Bold Move into Quantum-Powered Drug Discovery  parameter.io

SciSparc Ltd. (SPRC) Stock: Soars 50% on Bold Move into Quantum-Powered Drug Discovery - parameter.io

Click here to get full coverage on SciSparc And AutoMax Call Off Merger - Benzinga

SciSparc And AutoMax Call Off Merger  Benzinga

SciSparc And AutoMax Call Off Merger - Benzinga

Click here to get full coverage on SciSparc stock soars after launching quantum computing initiative - Investing.com

SciSparc stock soars after launching quantum computing initiative  Investing.com

SciSparc stock soars after launching quantum computing initiative - Investing.com

Click here to get full coverage on SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition - Nasdaq

SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition  Nasdaq

SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition - Nasdaq

Click here to get full coverage on SciSparc Ltd. Enters Definitive Agreement to Acquire Controlling Interest in Miza III Ventures Inc. Valued at Approximately US$11.6 Million | SPRC Stock News - Quiver Quantitative

SciSparc Ltd. Enters Definitive Agreement to Acquire Controlling Interest in Miza III Ventures Inc. Valued at Approximately US$11.6 Million | SPRC Stock News  Quiver Quantitative

SciSparc Ltd. Enters Definitive Agreement to Acquire Controlling Interest in Miza III Ventures Inc. Valued at Approximately US$11.6 Million | SPRC Stock News - Quiver Quantitative

Click here to get full coverage on Suicide Prevention Research Collaborative (SPRC) - Sunnybrook Hospital

Suicide Prevention Research Collaborative (SPRC)  Sunnybrook Hospital

Suicide Prevention Research Collaborative (SPRC) - Sunnybrook Hospital

Click here to get full coverage on STAR PETROLEUM REFINING Plc. (SPRC): More Positive On Earnings As OPEX Pressure Eases - Smartkarma

STAR PETROLEUM REFINING Plc. (SPRC): More Positive On Earnings As OPEX Pressure Eases  Smartkarma

STAR PETROLEUM REFINING Plc. (SPRC): More Positive On Earnings As OPEX Pressure Eases - Smartkarma

Click here to get full coverage on SciSparc Announces 1-for-21 Reverse Share Split - GlobeNewswire

SciSparc Announces 1-for-21 Reverse Share Split  GlobeNewswire

SciSparc Announces 1-for-21 Reverse Share Split - GlobeNewswire

Click here to get full coverage on SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewswire

SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer  GlobeNewswire

SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewswire

Click here to get full coverage on SPRC Announces THB0.15 Dividend Payment following 2Q25 Earnings Report - kaohoon international

SPRC Announces THB0.15 Dividend Payment following 2Q25 Earnings Report  kaohoon international

SPRC Announces THB0.15 Dividend Payment following 2Q25 Earnings Report - kaohoon international

Click here to get full coverage on SciSparc Shares Surge: Time to Invest? - timothysykes.com

SciSparc Shares Surge: Time to Invest?  timothysykes.com

SciSparc Shares Surge: Time to Invest? - timothysykes.com

Click here to get full coverage on SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel - GlobeNewswire

SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel  GlobeNewswire

SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel - GlobeNewswire

Click here to get full coverage on SciSparc Ltd. Announces Initiative to Advance 3D Protein Modeling with Quantum Computing Technology - Quiver Quantitative

SciSparc Ltd. Announces Initiative to Advance 3D Protein Modeling with Quantum Computing Technology  Quiver Quantitative

SciSparc Ltd. Announces Initiative to Advance 3D Protein Modeling with Quantum Computing Technology - Quiver Quantitative

Click here to get full coverage on SciSparc and AutoMax Motors terminate merger agreement - Investing.com

SciSparc and AutoMax Motors terminate merger agreement  Investing.com

SciSparc and AutoMax Motors terminate merger agreement - Investing.com

Click here to get full coverage on N2OFF stockholders approve MitoCareX Bio acquisition - Investing.com

N2OFF stockholders approve MitoCareX Bio acquisition  Investing.com

N2OFF stockholders approve MitoCareX Bio acquisition - Investing.com

Click here to get full coverage on SciSparc Announces Closing of the Acquisition of a Publicly - GlobeNewswire

SciSparc Announces Closing of the Acquisition of a Publicly  GlobeNewswire

SciSparc Announces Closing of the Acquisition of a Publicly - GlobeNewswire

Click here to get full coverage on SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors - GlobeNewswire

SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors  GlobeNewswire

SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors - GlobeNewswire

Click here to get full coverage on SPRC Stays Firm on Driving Strong Performance and Deliver Superior Shareholder Returns - kaohoon international

SPRC Stays Firm on Driving Strong Performance and Deliver Superior Shareholder Returns  kaohoon international

SPRC Stays Firm on Driving Strong Performance and Deliver Superior Shareholder Returns - kaohoon international

Click here to get full coverage on SciSparc to launch quantum computing initiative for 3D protein modeling - Investing.com

SciSparc to launch quantum computing initiative for 3D protein modeling  Investing.com

SciSparc to launch quantum computing initiative for 3D protein modeling - Investing.com

Click here to get full coverage on SciSparc Ltd. Announces One-for-Twenty One Reverse Share Split Effective July 3, 2025 - Nasdaq

SciSparc Ltd. Announces One-for-Twenty One Reverse Share Split Effective July 3, 2025  Nasdaq

SciSparc Ltd. Announces One-for-Twenty One Reverse Share Split Effective July 3, 2025 - Nasdaq

Click here to get full coverage on SciSparc stock soars after deal to gain controlling stake in Miza III Ventures - Investing.com

SciSparc stock soars after deal to gain controlling stake in Miza III Ventures  Investing.com

SciSparc stock soars after deal to gain controlling stake in Miza III Ventures - Investing.com

Click here to get full coverage on SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire

SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to  GlobeNewswire

SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire

Click here to get full coverage on Press release issued by SciSparc Ltd. titled “SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio.” - SEC.gov

Press release issued by SciSparc Ltd. titled “SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio.”  SEC.gov

Press release issued by SciSparc Ltd. titled “SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio.” - SEC.gov

Click here to get full coverage on SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio - GlobeNewswire

SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio  GlobeNewswire

SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio - GlobeNewswire

Click here to get full coverage on SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Sahm

SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures  Sahm

SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Sahm

Click here to get full coverage on SciSparc Ltd. Faces Merger Uncertainty with AutoMax - TipRanks

SciSparc Ltd. Faces Merger Uncertainty with AutoMax  TipRanks

SPRC

Price Chart

Key Statistics

Technicals

About SPRC

Latest News

SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Districts to Hold SPRC Training Sessions in Each District - Louisiana UMC

SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity - Stock Titan

Advanced Charts

Top Gainers

Top Losers